The AWARE Study

aware

More Information

If you would like to find out more, please send your information to the study team online, and the coordinator will contact you. You can also call toll free at 1-844-563-6679, or email memory@lifespan.org.

Sign up to get more information

Sponsored by AbbVie, AWARE is a multiple dose multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of ABBV-8E12 in subjects with early Alzheimer’s disease.

Intended for subjects with mild cognitive impairment or early Alzheimer’s disease, the study drug in the AWARE trial is an experimental antibody treatment which targets Tau protein.

People who may be able to take part in this study:

  • Are 55-85 years old
  • Have symptoms of early Alzheimer’s disease
  • Have a study partner who can go to some study visits to answer questions about the study participant’s symptoms

If you would like to find out more, please send your information to the study team online, and the coordinator will contact you. You can also call toll free at 1-844-563-6679, or email memory@lifespan.org.

Learn more about ongoing research projects at the Alzheimer's Disease and Memory Disorders Center